Quartz
Subscribe
Quartz
Subscribe
Edition
Business News
A.I.
Technology
Money & Markets
Leadership
Lifestyle
Latest

Get Quartz in your inbox

Free daily briefing on global business news.

Business News
AirlinesAutomobilesFoodPharmaceuticalsPolitics & GovernmentRetail & EcommerceSpace & AerospaceEarnings
Technology
A.I.ComputingConsumer TechSpace & AerospaceEarnings
Money & Markets
Economic IndicatorsMarketsPersonal FinanceEarnings
Lifestyle
Cars & BikesCollectingEntertainmentFood & Fine DiningHealth and FitnessReal EstateTravel
Quartz

Global business news for a smarter world

Topics

  • Business News
  • Money & Markets
  • Tech & Innovation
  • Generation A.I.
  • Lifestyle
  • Leadership

Products

  • Daily Brief
  • Weekly Digest
  • Member Benefits
  • Quartz Pro

Legal

  • Sitemap
  • About
  • Accessibility
  • Privacy
  • Terms of Service
  • Advertising

© 2026 Quartz Media, Inc. All rights reserved.

Business News

Medicare wants to make these generic drugs available for just $2

The program could start as early as 2027 and is meant to help boost drug adherence and health outcomes

By Bruce Gil·2 min read·Updated October 9, 2024
Add QZ to Google

The Centers for Medicare and Medicaid Services (CMS) just shared a preliminary list of generic drugs it plans to make available to Medicare recipients for $2 in a pilot program.


The program, which could start as early as 2027, will give people enrolled in a participating Medicare prescription drug plan access to dozens of generic drugs for a fixed copayment of no more than $2 for a month’s supply of a drug.

“The Medicare $2 Drug List Model will aim to help improve access to and affordability of low-cost generic drugs for people with Medicare prescription drug coverage, and we encourage the public to provide feedback on the model,” said CMS Administrator Chiquita Brooks-LaSure in a press release.


Ozempic and prescription weight loss drugs: How they work, what they cost, side effects, and everything to know

The pilot program is meant to asses whether access to low-cost generics could improve drug adherence, health outcomes, and satisfaction with Medicare drug plans.

The drugs on the initial list aim to target common conditions such as high cholesterol and high blood pressure — they include penicillin, metformin, and inhalers.

About 95% (or 40 million) of Medicare beneficiaries have filed a prescription for a drug on the list, according to CMS.

“The initial version of the $2 Drug List represents a starting point for the drug list that would be included in the model,” said Liz Fowler, CMS deputy administrator and director of the Innovation Center. “CMS intends to include many drugs that are used to treat common conditions for people with Medicare, with periodic updates to the drug list once it is finalized.”

CMS added that generic drug launches, changing clinical indications, and trends in pricing will require updates to the $2 Drug List before the launch of the program and at regular intervals throughout the course of the pilot.

Daily Brief

The essential business news, delivered fresh every morning.

Join 500,000+ readers who start their day with Quartz.

By subscribing, you agree to our Terms of Service and Privacy Policy.

Related

Cloud ComputingVerizon lands a $1 billion-plus dark fiber deal with Google for AI data centers
Politics & GovernmentTrump vows new tariffs on the E.U. after Brussels fines Google $1 billion
Politics & GovernmentTrump rolls out new forced-labor tariffs on 60 countries as trading partners push back
A.I.Samsung and SK Hynix are set to announce major memory chip deals with U.S. tech firms
A.I.Meta is upgrading its AI assistant to automate recurring tasks and daily briefings